{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-096092","form_type":"8-K","ticker":"VYNE","cik":"0001566044","company_name":"VYNE Therapeutics Inc.","filed_at":"2022-08-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.191444+00:00","generated_at":"2026-06-23T19:26:33.866234+00:00","sec_items":["3.01","8.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"VYNE receives Nasdaq extension to Feb 2023; pays Tay £850k for BETi compounds","bullets":["Nasdaq granted 180-day extension until Feb 27, 2023 to regain minimum $1.00 bid price for 10 consecutive days.","VYNE common stock transferred from Nasdaq Global Select to Capital Market, effective Aug 31, 2022.","VYNE paid Tay Therapeutics £850,000 after receipt of Oral BETi Compounds meeting specified molecular profile.","Company expects to exercise exclusive option on Oral BETi Compounds by end of 2022, before Feb 28, 2023 expiry.","If compliance not regained by Feb 27, 2023, Nasdaq will delist; VYNE may appeal or consider reverse stock split."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-096092","json":"https://secwatch.observer/filing/0001104659-22-096092.json","markdown":"https://secwatch.observer/filing/0001104659-22-096092.md","text":"https://secwatch.observer/filing/0001104659-22-096092.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1566044/000110465922096092/0001104659-22-096092-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1566044/000110465922096092/tm2224821d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T19:26:33.866234+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}